Drug therapy of Alzheimer dementia
Skausig, O.Bjørn.; Laugesem, L.P.; Jensen, T.
Ugeskrift for Laeger 165(29): 2899; Author Reply 2899-900
2003
ISSN/ISBN: 0041-5782 PMID: 12908363 Document Number: 554158
Document emailed within 1 workday
Related Documents
Patterson, M.B.; Mack, J.L.; Mackell, J.A.; Thomas, R.; Tariot, P.; Weiner, M.; Whitehouse, P.J. 1997: A longitudinal study of behavioral pathology across five levels of dementia severity in Alzheimer's disease: the CERAD Behavior Rating Scale for Dementia. the Alzheimer's Disease Cooperative Study Alzheimer Disease and Associated Disorders 11(Suppl 2): S40-S44Manning, F.C. 1994: Tacrine therapy for the dementia of Alzheimer's disease American Family Physician 50(4): 819-826
Frölich, L.; Padberg, F.; Kratzsch, T.; Maurer, K.; Möller, H.J.; Hampel, H. 2000: Therapy of Alzheimer dementia. Current status and prospects MMW Fortschritte der Medizin 142(25): 30-34
Doody, R.; Whitehouse, P.J.; Chen, Q.; Wang, L.; Wu, Q.; Rosser, M.; Xu, X.H. 1998: Alzheimer disease-related activities in China: a report from the International Working Group on the Harmonization of Dementia Drug Guidelines Alzheimer disease and associated disorders 12(4): 263-265
Li, W.P.; Yao, Z.B.; Yang, W.J.; Chen, Y.C.; Peng, W.H.; Hu, P. 1994: Study of the external counterpulsation (ECP) therapy for senile dementia of the Alzheimer's type (SDAT) Chinese Medical Journal 107(10): 755-760
Higashiyama, S.; Kawabe, J.; Hashimoto, H.; Akiyama, H.; Kawamura, E.; Torii, K.; Inoue, K.; Kiriike, N.; Shiomi, S.; Inoue, Y. 2006: 3DSRT evaluation of responses of Alzheimer type dementia to donepezil hydrochloride therapy Osaka City Medical Journal 52(2): 55-62
Higashiyama, S.; Kawabe, J.; Hashimoto, H.; Akiyama, H.; Kawamura, E.; Torii, K.; Inoue, K.; Kiriike, N.; Shiomi, S.; Inoue, Y. 2006: 3DSRT evaluation of responses of Alzheimer type dementia to donepezil hydrochloride therapy Osaka City Medical Journal 52(2): 55-62
Fărcăşel, L. 1988: Current data on the anatomy and physiopathology of Alzheimer's disease (Alzheimer-type senile dementia--ATSD) Revista Medico-Chirurgicala A Societatii de Medici Si Naturalisti Din Iasi 92(2): 289-292
Robles, A.; Touriño, R.; Gude, F.; Noya, M. 1999: The tropicamide test in patients with dementia of Alzheimer type and frontotemporal dementia Functional Neurology 14(4): 203-207
Lang, C. 1990: Diagnosis of Alzheimer's dementia. 2. Severity--differentiation from vascular forms of dementia (Hachinski Score) Fortschritte der Medizin 108(34): 657-659
Ball, M.J.; Kaye, J.A.; Steiner, I. 1997: Neocortical temporal lobe sclerosis masquerading as Alzheimer dementia: does herpes virus encephalopathy protect against Alzheimer's disease? Clinical Neuropathology 16(1): 1-12
Shefer, V.F. 1984: Relation between the degree of severity of the dementia and the extent of the manifestation of the pathomorphological changes in the cerebral cortex in senile dementia and Alzheimer's disease Zhurnal Nevropatologii i Psikhiatrii Imeni S.S. Korsakova 84(7): 1004-1006
Jindahra, P.; Vejjajiva, A.; Witoonpanich, R.; Sirisriro, R.; Sritara, C.; Pulkes, T. 2004: Differentiation of dementia with Lewy bodies, Alzheimer's disease and vascular dementia by cardiac 131I-meta-iodobenzylguanidine (MIBG) uptake (preliminary report) Journal of the Medical Association of Thailand 87(10): 1176-1181
Yoshii, F.; Shinohara, Y.; Duara, R. 1990: Cerebral white matter bundle alterations in patients with dementia of Alzheimer type and patients with multi-infarct dementia--magnetic resonance imaging study Rinsho Shinkeigaku 30(1): 110-112
Lacomblez, L. 1998: Drug therapy strategies in Alzheimer's disease La Revue du Praticien 48(17): 1913-1917
Otomo, E. 1988: Drug therapy of Alzheimer's disease. General concepts on nootropic drugs Nihon Rinsho. Japanese Journal of Clinical Medicine 46(7): 1569-1574
Bodick, N.; Forette, F.; Hadler, D.; Harvey, R.J.; Leber, P.; McKeith, I.G.; Riekkinen, P.J.; Rossor, M.N.; Scheltens, P.; Shimohama, S.; Spiegel, R.; Tanaka, S.; Thal, L.J.; Urata, Y.; Whitehouse, P.; Wilcock, G. 1997: Protocols to demonstrate slowing of Alzheimer disease progression. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines. The Disease Progression Sub-Group Alzheimer Disease and Associated Disorders 11 Suppl. 3: 50-53
Dassel, K.; Utz, R.; Supiano, K.; Bybee, S.; Iacob, E. 2019: Development of a Dementia-Focused End-of-Life Planning Tool: the LEAD Guide (Life-Planning in Early Alzheimer's and Dementia) Innovation in Aging 3(3): Igz024
Dassel, K.; Utz, R.; Supiano, K.; Bybee, S.; Iacob, E. 2019: Development of a Dementia-Focused End-of-Life Planning Tool: the LEAD Guide (Life-Planning in Early Alzheimer's and Dementia) Innovation in Aging 3(3): Igz024
Mas, J.L.; Alperovitch, A.; Derouesne, C. 1987: Epidemiology of Alzheimer's type dementia Revue Neurologique (Paris) 143(3): 161-171